Bank Of America Corp Alkermes Plc. Call Options Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 15, 2024
BUY
$26.4 - $32.56 $976,800 - $1.2 Million
37,000 New
37,000 $1 Million
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $1.66 Million - $1.97 Million
58,700 New
58,700 $1.84 Million
Q2 2021

Sep 13, 2021
BUY
$18.78 - $25.15 $563,400 - $754,500
30,000 New
30,000 $736,000

Others Institutions Holding ALKS

# of Institutions
346
Shares Held
183M
Call Options Held
209K
Put Options Held
89.4K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.54B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email